Key result
Different ablation endpoints (slow pathway elimination vs improvement) had no apparent impact on recurrence rate (0% vs 2.38%) or myocardial function in patients with AVNRT.
Why the study?
The study aimed to evaluate the effectiveness of atrioventricular nodal slow pathway ablation in AVNRT patients and examine its impact on atrioventricular conduction function.
Does slow pathway elimination compared to slow pathway improvement during radiofrequency ablation affect atrioventricular conduction function and recurrence in patients with AVNRT?
Population
90 AVNRT patients who underwent radiofrequency ablation
Comparison
Slow pathway elimination group vs slow pathway improvement group
Design
Retrospective observational study
Follow-up
2 years post-ablation
Authors
Loading...
Endpoint choice appears interchangeable for AVNRT ablation without affecting recurrence; leaves open prospective trials to guide practice.
Observational (n=90)
No
Does slow pathway elimination compared to slow pathway improvement during radiofrequency ablation affect atrioventricular conduction function and recurrence in patients with AVNRT?
Absolute Event Rate: 0% vs 2.38%
In patients with AVNRT undergoing radiofrequency ablation, achieving slow pathway improvement versus complete elimination results in different electrophysiological changes but similar excellent clinical outcomes with low recurrence rates.
Wang et al. (2024) conducted an observational in Atrioventricular nodal reentrant tachycardia (AVNRT) (n=90). Slow pathway elimination (SPE) vs. Slow pathway improvement (SPI) was evaluated on Recurrence rate at 2 years post-ablation. Different ablation endpoints (slow pathway elimination vs improvement) had no apparent impact on recurrence rate (0% vs 2.38%) or myocardial function in patients with AVNRT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: